News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK)'s Gardasil HPV Vaccine Doesn't Increase Blood Clot Risk


7/9/2014 6:11:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A new post-approval study of over 1.6 million Danish women has shown that the quadrivalent human papillomavirus (HPV) vaccine poses no increased risk of blood clots at any time within 42 days of receiving the immunization. The report appears in the July 9th issue of JAMA, the Journal of the American Medical Association.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes
Read at News Release
Read at US News
Read at JAMA
Read at ScienceDaily

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES